IGF-1 ELISA Assay: Principle, Protocol, Sample Requirements, and Applications

The IGF-1 ELISA assay is a highly sensitive sandwich immunoassay designed for the quantitative measurement of insulin-like growth factor 1 in serum, plasma, and other biological samples. As a critical biomarker of growth hormone activity and metabolic status, accurate IGF-1 quantification supports endocrine diagnostics, growth disorder screening, and broad biomedical research applications. This article provides a comprehensive technical guide covering assay principle, sample preparation, testing methodology, and practical troubleshooting.

Technical Overview

Insulin-like Growth Factor 1 (IGF-1), also known as somatomedin C, is a 70-amino acid single-chain polypeptide with a molecular weight of approximately 7.6 kDa. It belongs to the insulin-like growth factor family and shares significant structural homology with proinsulin. IGF-1 is produced primarily by the liver under the regulation of growth hormone (GH) and acts as the principal mediator of growth hormone effects on peripheral tissues, promoting cell proliferation, differentiation, and survival.

The IGF-1 ELISA experiment is an enzyme-linked immunosorbent assay that quantifies IGF-1 concentrations in biological fluids using a double-antibody sandwich format. The assay employs a capture antibody immobilized on a 96-well microplate and a detection antibody conjugated to horseradish peroxidase (HRP). When the enzyme substrate 3,3',5,5'-tetramethylbenzidine (TMB) is added, the resulting colorimetric signal is directly proportional to the IGF-1 concentration present in the sample.

A distinctive technical challenge in IGF-1 measurement is that more than 95% of circulating IGF-1 is bound to high-affinity IGF-binding proteins (IGFBPs), particularly IGFBP-3. This complexation can mask epitopes and interfere with antibody binding. Consequently, most commercial IGF-1 ELISA kits incorporate a pretreatment step, typically acid-ethanol extraction or an acidic dissociation buffer, to release free IGF-1 from IGFBPs before measurement. This step is essential for obtaining accurate and reproducible results.

Testing Samples

Serum

Serum is the most commonly used sample type for IGF-1 ELISA. Whole blood should be collected using a standard serum tube and allowed to clot at room temperature for 30 to 60 minutes, followed by centrifugation at 1,000 to 2,000 × g for 10 to 15 minutes. Hemolyzed, lipemic, or repeatedly freeze-thawed samples should be avoided, as they may produce erroneous readings. Serum samples are generally stable for up to 5 days at 2–8°C, and long-term storage requires aliquoting at -80°C.

Plasma

Plasma collected with EDTA or heparin anticoagulants is also acceptable for most kit protocols. Centrifugation should be performed within 30 minutes of collection to remove cellular components. Citrate plasma may be acceptable for certain kits but should be validated by the user. As with serum, avoid multiple freeze-thaw cycles.

Cell Culture Supernatant

Conditioned media from cultured hepatocytes, fibroblasts, or other IGF-1-secreting cells can be assayed to evaluate secretory function. Remove particulates by centrifugation or filtration before analysis. If the expected concentration exceeds the upper limit of the standard curve, dilute the sample with the kit-provided sample diluent.

Tissue Homogenates and Other Biological Fluids

Tissue lysates, cerebrospinal fluid, follicular fluid, and milk samples from animal studies may be tested following appropriate homogenization, clarification, and validation of dilution linearity. Total protein normalization is recommended for tissue lysate data reporting.

Testing Items

The IGF-1 ELISA experiment primarily measures total IGF-1 concentration, expressed in ng/mL. Key performance specifications typically include the following:

• Detection range: commonly 1–400 ng/mL, varying by manufacturer and species
• Sensitivity (minimum detectable dose): typically 0.1–2 ng/mL
• Species reactivity: kits are available for human, mouse, rat, porcine, bovine, equine, canine, and other species
• Intra-assay precision: coefficient of variation (CV) below 8–10%
• Inter-assay precision: CV below 10–15%
• Sample volume: typically 50–100 µL per well after pretreatment
• Cross-reactivity: minimal cross-reactivity with IGF-2 and related peptides in well-designed kits

Testing Methods

Sample Pretreatment

Because circulating IGF-1 is complexed with IGFBPs, pretreatment is a critical first step. The classical method involves acid-ethanol extraction: mixing the sample with an acidified ethanol solution to dissociate IGF-1 from binding proteins, followed by neutralization and centrifugation to precipitate IGFBPs. Many modern kits simplify this with a one-step acidic sample diluent that achieves complete dissociation during a defined incubation period. Always follow the kit-specific pretreatment instructions, as untreated samples will yield falsely low results.

Assay Procedure

The standard sandwich ELISA workflow proceeds as follows:

• Equilibrate all reagents, standards, and samples to room temperature before starting
• Add pretreated standards, controls, and samples to the antibody-coated wells in duplicate
• Incubate for the specified period (typically 1–2 hours) at 37°C to allow antigen capture
• Wash the plate 3–5 times with wash buffer to remove unbound material
• Add the HRP-conjugated detection antibody and incubate
• Wash thoroughly to remove excess conjugate
• Add TMB substrate and incubate in the dark for 10–20 minutes as color develops
• Add stop solution; the color changes from blue to yellow
• Read absorbance at 450 nm (with 570 or 620 nm reference correction if available) within 15 minutes

Data Analysis

Construct a standard curve by plotting absorbance values against known IGF-1 concentrations, then fit the data using a four-parameter logistic (4-PL) regression model. Calculate sample concentrations from the curve and multiply by the appropriate dilution factor to account for pretreatment and sample dilution. Results falling outside the standard curve range should be re-analyzed at adjusted dilutions. Acceptance criteria typically require duplicate CVs below 15% and control samples within established ranges.

Applications

The IGF-1 ELISA experiment serves a wide spectrum of clinical and research purposes:

• Growth disorder diagnosis: screening for growth hormone deficiency in short-stature children and supporting the diagnosis of GH resistance syndromes such as Laron syndrome
• Acromegaly and gigantism management: IGF-1 is the recommended first-line biomarker for diagnosis and post-treatment monitoring of GH-secreting pituitary adenomas
• Nutritional assessment: IGF-1 is a sensitive marker of protein-energy status and responds rapidly to nutritional intervention
• Metabolic and endocrine research: investigating GH/IGF-1 axis regulation, insulin sensitivity, and liver function
• Oncology research: evaluating the role of IGF-1 signaling in tumor proliferation and therapeutic response
• Sports science and anti-doping: longitudinal monitoring of IGF-1 as part of the athlete biological passport
• Animal and veterinary science: assessing growth performance, somatotropic axis function, and lactation physiology in livestock and companion animals

FAQ

Why is sample pretreatment necessary for IGF-1 ELISA?

The majority of circulating IGF-1 is sequestered within IGFBP complexes, which physically block antibody-accessible epitopes. Acidic pretreatment dissociates these complexes, allowing measurement of total IGF-1. Skipping this step leads to significant underestimation of true concentration.

How should samples be stored before testing?

Store samples at 2–8°C if analysis occurs within 48–72 hours. For longer storage, aliquot and freeze at -80°C. Repeated freeze-thaw cycles must be avoided because they degrade the analyte and increase result variability.

What causes a poor or flat standard curve?

Common causes include incorrect reagent preparation, inadequate washing, expired standards, substrate exposure to light, and incubation at incorrect temperatures. Verify reagent integrity, calibrate the microplate washer, and maintain strict timing and temperature control.

Can one kit detect IGF-1 across multiple species?

No. IGF-1 sequence conservation is high but antibody affinity varies considerably between species. Always select a kit validated for the specific species under investigation to ensure accuracy.

How are out-of-range samples handled?

Samples exceeding the highest standard should be diluted further with the appropriate diluent and re-assayed, with the dilution factor applied during calculation. Samples below the detection limit should be reported as below the minimum detectable concentration.

What quality control practices are recommended?

Run samples in duplicate, include internal quality controls at low, medium, and high concentrations on every plate, monitor intra- and inter-assay CVs, and participate in external quality assessment programs for clinical applications to ensure long-term result comparability.